Premium
Erratum: Management of nocturia
Author(s) -
Khan Faisal Rauf,
Younis Ayman,
Alosta Ahmed,
Khan Shahid A.A.
Publication year - 2011
Publication title -
trends in urology and men's health
Language(s) - English
Resource type - Journals
eISSN - 2044-3749
pISSN - 2044-3730
DOI - 10.1002/tre.237
Subject(s) - nocturia , desmopressin , medicine , nasal administration , urology , anesthesia , pharmacology , urinary system
In the article on management of nocturia (Sep/Oct 2011;2(5):35–7), the doses of desmopressin given on page 36 were incorrect. The following statements are correct: treatment with desmopressin should be initiated at a dose of 50–100 micrograms orally, with a weekly dose escalation to a maximum of 400 micrograms; the intranasal formulation provides 10 micrograms/spray, and can be used up to a maximum dose of 40 micrograms/day. We apologise to readers for this error.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom